President and CEO, Clinical Genomics

Dr Lawrence LaPointe

Role	Organisation	Sources
President and CEO	Clinical Genomics	einpresswire.com

Coverage

Stories naming Dr Lawrence LaPointe. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Series A $15m

Clinical Genomics Announces Closing of $15 Million Series A Financing Round

Diagnostics company Clinical Genomics closed a $15m Series A led by Sydney VC OneVentures to commercialise its blood test for monitoring bowel cancer recurrence; OneVentures partner Dr Paul Kelly joins its board.

einpresswire.com 23 Mar 2016 Clinical Genomics OneVentures Dr Lawrence LaPointe Dr Paul Kelly

Something wrong? Tell us

Dr Lawrence LaPointe

Roles

Coverage

Clinical Genomics Announces Closing of $15 Million Series A Financing Round